marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-14-2023
Bellicum Pharmaceuticals Balance Sheet 2011-2024 | BLCM
Annual Balance Sheet Bellicum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | -34.7 M | -54.3 M | 41.4 M | 56.2 M | -12.9 M | -70.1 M | -192 M | -10.4 M | -1.18 M | - |
Long Term Debt |
- | - | - | 25.7 M | 35.8 M | 34.9 M | 18.4 M | - | - | 400 K | 360 K | - |
Long Term Debt Current |
- | - | - | 11 M | - | - | 1.79 M | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 48 M | 37.2 M | 38.7 M | 20.4 M | 944 K | 522 K | 40.9 M | 22.4 M | - |
Total Current Liabilities |
3.77 M | 6.71 M | 24.7 M | 94.4 M | 15.8 M | 12.2 M | 15.1 M | 7.44 M | - | - | - | - |
Total Liabilities |
3.77 M | 6.71 M | 25 M | 142 M | 53 M | 50.9 M | 35.5 M | 8.39 M | 4.16 M | 43.1 M | 24.7 M | - |
Deferred Revenue |
- | - | - | - | 2.98 M | 2.05 M | - | - | 13.1 K | - | 1.04 M | - |
Retained Earnings |
-575 M | -550 M | - | -533 M | -421 M | -323 M | -231 M | -161 M | -113 M | -29 M | -21 M | - |
Total Assets |
23.8 M | 49.1 M | 40.6 M | 116 M | 122 M | 136 M | 132 M | 160 M | 196 M | 14.9 M | 5.19 M | - |
Cash and Cash Equivalents |
21.8 M | 46.2 M | 35.5 M | 91 M | 43.7 M | 38.8 M | 33.1 M | 70.2 M | 192 M | - | - | - |
Book Value |
20.1 M | 42.4 M | 15.5 M | -26.2 M | 68.5 M | 84.6 M | 96.6 M | 152 M | 192 M | -28.2 M | -19.5 M | - |
Total Shareholders Equity |
2.02 M | 24.4 M | -2.5 M | -26.2 M | 68.5 M | 84.6 M | 96.6 M | 152 M | 192 M | -28.2 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet Bellicum Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | 17.7 M | 20.7 M | 23.7 M | 25.7 M | 25.7 M | 25.7 M | 25.7 M | 35.8 M | 35.6 M | 35.8 M | 35.8 M | 34.9 M | 23.8 M | 34.9 M | 34.9 M | 18.4 M | 20.1 M | 18.4 M | 18.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
2.25 M | 3.48 M | 4.72 M | 3.77 M | 5.75 M | 4.53 M | 7.97 M | 6.71 M | 16.5 M | 20.2 M | 26.3 M | 25 M | 25 M | 25 M | 25 M | 121 M | 121 M | 121 M | 121 M | 53 M | 53 M | 53 M | 53 M | 50.9 M | 50.9 M | 50.9 M | 50.9 M | 35.5 M | 35.5 M | 35.5 M | 35.5 M | 8.39 M | 8.39 M | 8.39 M | 8.39 M | 4.16 M | 4.16 M | 4.16 M | 4.16 M | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 973 K | 1.08 M | 2.47 M | 2.98 M | 2.98 M | 3.59 M | 3.19 M | 2.05 M | 2.05 M | - | 2.05 M | - | - | - | - | - | - | - | - | 13 K | 13 K | 13 K | 13 K | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-592 M | -591 M | -583 M | -575 M | -569 M | -562 M | -558 M | -550 M | -553 M | -554 M | -552 M | -541 M | -541 M | -541 M | -541 M | -533 M | -533 M | -533 M | -533 M | -421 M | -421 M | -421 M | -421 M | -323 M | -323 M | -323 M | -323 M | -231 M | -231 M | -231 M | -231 M | -161 M | -161 M | -161 M | -161 M | -113 M | -113 M | -113 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
6.85 M | 8.73 M | 17.3 M | 23.8 M | 31.3 M | 36.6 M | 43.4 M | 49.1 M | 22.4 M | 24 M | 31.5 M | 40.6 M | 40.6 M | 40.6 M | 40.6 M | 116 M | 116 M | 116 M | 116 M | 122 M | 122 M | 122 M | 122 M | 136 M | 136 M | 136 M | 136 M | 132 M | 132 M | 132 M | 132 M | 160 M | 160 M | 160 M | 160 M | 196 M | 196 M | 196 M | 196 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
5.91 M | 7.41 M | 15.4 M | 21.8 M | 28.8 M | 34.7 M | 39.8 M | 46.2 M | 20.8 M | 21.8 M | 28.1 M | 35.5 M | 35.5 M | 35.5 M | 35.5 M | 91 M | 91 M | 91 M | 91 M | 43.7 M | 43.7 M | 43.7 M | 43.7 M | 38.8 M | 38.8 M | 38.8 M | 38.8 M | 33.1 M | 33.1 M | 33.1 M | 33.1 M | 70.2 M | 70.2 M | 70.2 M | 70.2 M | 192 M | 192 M | 192 M | 192 M | 11.2 M | - | - | - | 1.63 M | - | - | - | - | - | - | - |
Book Value |
4.6 M | 5.25 M | 12.5 M | 20.1 M | 25.5 M | 32.1 M | 35.5 M | 42.4 M | 5.87 M | 3.79 M | 5.18 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | -4.75 M | -4.75 M | -4.75 M | -4.75 M | 68.5 M | 68.5 M | 68.5 M | 68.5 M | 84.6 M | 84.6 M | 84.6 M | 84.6 M | 96.6 M | 96.6 M | 96.6 M | 96.6 M | 152 M | 152 M | 152 M | 152 M | 192 M | 192 M | 192 M | 192 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-27 M | -21.8 M | -10 M | 2.02 M | 7.5 M | 14 M | 17.4 M | 24.4 M | -12.2 M | -14.2 M | -12.9 M | -2.5 M | -2.5 M | -2.5 M | -2.5 M | -26.2 M | -26.2 M | -26.2 M | -26.2 M | 68.5 M | 68.5 M | 68.5 M | 68.5 M | 84.6 M | 84.6 M | 84.6 M | 84.6 M | 96.6 M | 96.6 M | 96.6 M | 96.6 M | 152 M | 152 M | 152 M | 152 M | 192 M | 192 M | 192 M | 192 M | -28.2 M | - | - | - | -19.5 M | - | - | - | - | - | - | - |
All numbers in USD currency